Plante Moran Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-46
Closed -$8.26K 812
2025
Q2
$8.26K Hold
46
﹤0.01% 586
2025
Q1
$7.78K Hold
46
﹤0.01% 603
2024
Q4
$6.94K Hold
46
﹤0.01% 642
2024
Q3
$7.14K Hold
46
﹤0.01% 643
2024
Q2
$6.3K Hold
46
﹤0.01% 629
2024
Q1
$6.12K Hold
46
﹤0.01% 671
2023
Q4
$6.34K Hold
46
﹤0.01% 620
2023
Q3
$5.61K Hold
46
﹤0.01% 591
2023
Q2
$6.47K Hold
46
﹤0.01% 610
2023
Q1
$6.51K Hold
46
﹤0.01% 622
2022
Q4
$7.2K Hold
46
﹤0.01% 619
2022
Q3
$6K Hold
46
﹤0.01% 657
2022
Q2
$6K Hold
46
﹤0.01% 677
2022
Q1
$6K Sell
46
-27
-37% -$3.76K ﹤0.01% 650
2021
Q4
$13K Buy
+73
New +$11.1K ﹤0.01% 632
2020
Q4
Sell
-67
Closed -$8K 906
2020
Q3
$8K Buy
+67
New +$7.92K ﹤0.01% 630
2020
Q1
Sell
-366
Closed -$39K 751
2019
Q4
$39K Hold
366
0.01% 353
2019
Q3
$39K Hold
366
0.01% 377
2019
Q2
$37K Buy
+366
New +$35.2K 0.01% 386
2019
Q1
Sell
-65
Closed -$5K 804
2018
Q4
$5K Buy
+65
New +$6.09K ﹤0.01% 592

Other funds holding DGX

Plante Moran Financial Advisors's DGX Position: Q3 2025 in Review

Plante Moran Financial Advisors sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 46 shares — an estimated $8.26K sold.

Plante Moran Financial Advisors first reported a position in DGX in Q4 2018 and held it in 20 quarters. The position peaked at $39K in Q4 2019. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Plante Moran Financial Advisors reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 46 Quest Diagnostics shares in Q3 2025, an estimated $8.26K.
  • Plante Moran Financial Advisors first reported a position in Quest Diagnostics in Q4 2018 and held it in 20 quarters.
  • Plante Moran Financial Advisors's Quest Diagnostics position peaked at $39K in Q4 2019.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.